EUVIMEDEUVIMED entdecken
Crossref

Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium

Bachir Latli iD, Matt J Hrapchak, Jonathan T Reeves, Heewon Lee, Jinhua J Song

Journal of Labelled Compounds and Radiopharmaceuticals · 2023

DOI: 10.1002/jlcr.4022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2023. Verfasst von Bachir Latli und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The generation of amyloid beta peptides that aggregate in the brain is believed to play a major role in Alzheimer's disease. In theory, the inhibition of beta‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1), which catalyzes the initial rate‐limiting step in amyloid beta production, may slow or stop Alzheimer's disease. Herein, we report the preparation of two potent BACE1 inhibitors, BI 1147560 ( 1 ) and BI 1181181 ( 2 ), labeled with carbon‐14 and with deuterium. The use of advanced key chiral intermediates like 3 and 5 shortened the carbon‐14 syntheses of these two compounds to five and six steps, respectively, and helped in preparing them with very high chemical purity and enantiomeric excess without deviating from the process chemistry route. For the deuterium synthesis, oxetan‐3‐ylmethanamine [ 2 H 6 ]‐7 and 2‐fluoro‐2‐methylpropan‐1‐amine [ 2 H 6 ]‐9 were prepared then used with the chiral intermediate 5 to furnish deuterium labeled 1 and 2 , respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAmyloid beta-Protein PrecursorAspartic Acid EndopeptidasesCarbon RadioisotopesDeuteriumEnzyme Inhibitors

Stichwörter der Autor:innen

Alzheimer's diseaseBACE1 inhibitorscarbon-14deuteriumradiosynthesis

Substanzen

Amyloid beta-PeptidesAmyloid Precursor Protein SecretasesAmyloid beta-Protein PrecursorAspartic Acid EndopeptidasesCarbon-14Carbon RadioisotopesDeuteriumEnzyme Inhibitors

Autor:innen und Institutionen

  • The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.

ORCID-Profile: Bachir Latli

Zitieren

APA

Latli, B., Hrapchak, M. J., Reeves, J. T., Lee, H., & Song, J. J. (2023). Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4022

Vancouver

Latli B, Hrapchak MJ, Reeves JT, Lee H, Song JJ. Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. 2023. doi:10.1002/jlcr.4022

BibTeX
@article{Latli2023,
  author = {Latli, Bachir and Hrapchak, Matt J and Reeves, Jonathan T and Lee, Heewon and Song, Jinhua J},
  title = {Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2023},
  doi = {10.1002/jlcr.4022}
}
Kostenlos starten →